BRP, identified through peptide prediction, may revolutionize weight loss treatment, offering efficacy without the ...

BRP emerges as a promising peptide for weight loss, activating appetite control pathways without triggering nausea, paving ...

Wearable and implantable biosensors that can accurately detect biological molecules in a non- or minimally invasive manner ...

Rua Dr. Diogo de Faria, 1087 – 9º andar – Vila Clementino 04037-003 São Paulo/SP - Brasil E-mail: [email protected] ...

Cancer Discovery publishes high-impact articles featuring major advances in research and clinical trials. Topics span the spectrum of cancer research and medicine from the laboratory to the clinic to ...

The common diabetes drug metformin works partly by excreting sugar from the bloodstream into the intestines, where gut ...

A naturally occurring molecule identified by Stanford Medicine researchers appears similar to semaglutide—also known as ...

Portuguese researchers identified a type of immune cell that appears to travel to the pancreas to stimulate glucagon ...

A naturally occurring molecule identified by Stanford Medicine researchers appears similar to semaglutide - also known as Ozempic - in suppressing appetite and reducing body weight.

"Intestinal glucose excretion represents a previously unrecognized physiological process. Understanding its molecular mechanisms and how drugs influence this system could lead to the development of ...

ChREBP is a transcription factor that plays a crucial role in regulating glucose metabolism. It exists in two main isoforms: ChREBPα and ChREBPβ. This is the first study to identify and develop small ...

Gut microbes that were thought to feed exclusively on dietary fiber also get fed sugar from our guts, from which they produce short-chain fatty acids that are crucial to many body functions. The Kobe ...